Chromosomal microarray impacts clinical management
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Chromosomal microarray analysis (CMA) is standard of care, first‐tier clinical testing for detection of genomic copy number variation among patients with developmental disabilities. Although diagnostic yield is higher than traditional cytogenetic testing, management impact has not been well studied. We surveyed genetic services providers regarding CMA ordering practices and perceptions about reimbursement. Lack of insurance coverage because of perceived lack of clinical utility was cited among the most frequent reasons why CMA was not ordered when warranted. We compiled a list of genomic regions where haploinsufficiency or triplosensitivity cause genetic conditions with documented management recommendations, estimating that at least 146 conditions potentially diagnosable by CMA testing have published literature supporting specific clinical management implications. Comparison with an existing clinical CMA database to determine the proportion of cases involving these regions showed that CMA diagnoses associated with such recommendations are found in approximately 7% of all cases (n = 28,526). We conclude that CMA impacts clinical management at a rate similar to other genetic tests for which insurance coverage is more readily approved. The information presented here can be used to address barriers that continue to contribute to inequities in patient access and care in regard to CMA testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.006 · Cited by 2,882 · cited 2×
“5% among individuals with DD or ID (31–34)), but is lower than our projected 7% yield of clinically actionable results, and well below the overall reported diagnostic yield of CMA testing, estimated at 15–20% for similar patient populations (8).”
BackgroundSelf-citationIdentification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Genomics, Intellectual Disability, and Autism
Mefford, H. C., Batshaw, M. L., & Hoffman, E. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114194 · Cited by 329 · cited 1×
“Indeed, a number of genomic syndromes evaluated for this study have only been described within the last several years (2).”
BackgroundDeletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia
Moreno-De-Luca, D., Mulle, J. G., Kaminsky, E. B., Sanders, S. J., Myers, S. M., Adam, M. P., Pakula, A. T., Eisenhauer, N. J., Uhas, K., Weik, L., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.004 · Cited by 324 · cited 1×
“It is recommended that individuals with this condition be evaluated and monitored longitudinally for all features associated with the condition, not just their initial presenting features (37).”
BackgroundSelf-citation
Research works printed but not linked: 28
- 10.1097/GIM.0b013e3181f8baad · DOI · Paper page
- 10.1542/peds.2008-0297 · DOI · Paper page
- 10.1542/peds.2006-1006 · DOI · Paper page
- 10.1212/01.WNL.0000031431.81555.16 · DOI · Paper page
- 10.1097/GIM.0b013e31816b5cc9 · DOI · Paper page
- 10.1097/GIM.0b013e318194ee8f · DOI · Paper page
- 10.1016/j.ejmg.2009.03.015 · DOI · Paper page
- 10.1136/jmg.2005.036350 · DOI · Paper page
- 10.1002/ajmg.a.31842 · DOI · Paper page
- 10.1016/j.ajhg.2010.03.009 · DOI
- 10.1212/WNL.0b013e3182395d81 · DOI
- 10.1097/GIM.0b013e31821dd54a · DOI
- 10.1016/j.cppeds.2011.10.003 · doi:10.1016/j.cppeds.2011.10.003
- 10.1016/j.jpeds.2008.07.045 · DOI
- 10.1097/GIM.0b013e3181a028a5 · DOI
- 10.1097/GIM.0b013e318177015c · DOI · Paper page
- 10.1038/ejhg.2009.189 · DOI
- 10.1200/JCO.2002.20.6.1480 · DOI · Paper page
- 10.1212/WNL.55.4.468 · DOI · Paper page
- 10.1542/peds.2009-1684 · DOI · Paper page
- 10.1177/0009922811406261 · DOI · Paper page
- 10.1002/ajmg.a.31416 · DOI · Paper page
- 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.0.CO;2-4 · DOI
- 10.1002/ajmg.1320510436 · DOI · Paper page
- 10.1086/515496 · DOI · Paper page
- 10.1212/WNL.0b013e3182345896 · DOI · Paper page
- 10.1002/ajmg.a.32992 · DOI
- 10.2165/00024677-200504010-00002 · DOI
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Srivastava, S., Love-Nichols, J. A., Dies, K. A., Ledbetter, D. H., Martin, C. L., Chung, W. K., Firth, H. V., Frazier, T., Hansen, R. L., Prock, L., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0554-6 · Cited by 695
Self-citationThe impact of chromosomal microarray on clinical management: a retrospective analysis
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. S. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.18 · Cited by 71
Metadata
- Authors
- Riggs, E. R., Wain, K. E., Riethmaier, D., Smith‐Packard, B., Faucett, W. A., Hoppman, N., Thorland, E. C., Patel, V. C., & Miller, D. T.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2013-02-21
- Volume
- 85
- Issue
- 2
- Pages
- 147-153
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1835752389
- Cited by
- 89
- References
- 4
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.